2 Clinical-Stage Biotechs With Upside Potential Over 100%
Two clinical-stage biotech stocks with the potential to deliver gains of 100% or more.
Two clinical-stage biotech stocks with the potential to deliver gains of 100% or more.
What makes the genetic testing and sequencing company featured in today’s article potentially the best coronavirus stock investors can buy right now?
What are the most affordable biopharmaceutical growth stocks in the S&P 500 right now? Or, as today’s article puts it, which biopharma stocks in the… Read More »“The Most Growth, At The Cheapest Price”
While large-cap biotech stocks may come with less risk than their small-cap counterparts, the author of today’s article notes that “On the plus side small-cap… Read More »10 Under $10: The Best Small-Cap Biotech Stocks For 2021
Among the three biotech stocks to watch going forward in 2021 highlighted by the author of today’s article is a specialty company focused on developing… Read More »3 Biotech Stocks To Watch – Including A Pioneering CBD Company
When it comes to investing in biotech stocks, the author of today’s article points out that “By identifying companies that are likely to report rapid… Read More »On The Cusp Of Commercializing Its First Drug, Now May Be The Time To Buy This Biotech Stock
The genomic revolution in underway, with the author of today’s article noting that “artificial intelligence is converging with decades of breakthrough genomics research to create a new generation of hyper-efficient, hyper-accurate, and hyper-precise gene editing medicines.”
When it comes to the performance of healthcare companies during the pandemic, the author of today’s article notes that “Those best prepared for developing a… Read More »This Biotech Laggard Could Offer Traders A Market-Beating Opportunity
2020 Top Stock Picker shares insights on the outlook for genomics, electric vehicles, blockchain technology and more.
Small- And Mid-Cap Biotech Picks For 2021 and holdovers from 2020.